Literature DB >> 15139525

Effective transfection of rabies DNA vaccine in cell culture using an artificial lipoprotein carrier system.

Fars Alanazi1, Zhen F Fu, D Robert Lu.   

Abstract

PURPOSE: To evaluate the transfection efficiency in cell culture of rabies plasmid DNA vaccine carried by a novel artificial lipoprotein system.
METHODS: Phospholipid nanoemulsions resembling the lipid core of natural lipoproteins were prepared. The artificial lipoprotein carrier system for DNA was constructed by assembling of the nanoemulsion (NE)-palmitoyl-poly-L-lysine (p-PLL)-rabies DNA complex. Agarose gel electrophoresis, zeta potential, and mobility measurement were conducted to determine the surface charge balance in various complex compositions. Transfection and transfection efficiency were examined by fluorescence microscopy and flow cytometry, respectively.
RESULTS: The artificial lipoprotein system was successfully constructed and the rabies DNA vaccine was effectively transfected in glioma cell line SF-767. The amount of p-PLL incorporated into the artificial lipoprotein formulations had a significant effect on transfection efficiency. The new system also proved to be more efficient in cellular transfection of rabies DNA vaccine than the commercial lipofectamine formulation.
CONCLUSIONS: Effective transfection of rabies DNA vaccine in cell culture can be achieved using the novel artificial lipoprotein carrier system, and the charge balance of the NE-p-PLL-DNA complex appears an important factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139525     DOI: 10.1023/b:pham.0000022415.74531.d9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  Development of biomaterials for gene therapy.

Authors:  S Han; R I Mahato; Y K Sung; S W Kim
Journal:  Mol Ther       Date:  2000-10       Impact factor: 11.454

2.  In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system.

Authors:  Guangliang Pan; Mohannad Shawer; Svein Oie; D Robert Lu
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 3.  Microparticles and nanoparticles as delivery systems for DNA vaccines.

Authors:  Zhengrong Cui; Russell J Mumper
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2003       Impact factor: 4.889

4.  In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector.

Authors:  T Hara; Y Tan; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.

Authors:  N B Ray; L C Ewalt; D L Lodmell
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

6.  Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo.

Authors:  H Madry; R Reszka; J Bohlender; J Wagner
Journal:  J Mol Med (Berl)       Date:  2001-05       Impact factor: 4.599

7.  Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.

Authors:  Z F Fu; C E Rupprecht; B Dietzschold; P Saikumar; H S Niu; I Babka; W H Wunner; H Koprowski
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

8.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

Review 9.  Alphavirus vectors for gene therapy applications.

Authors:  K Lundstrom
Journal:  Curr Gene Ther       Date:  2001-05       Impact factor: 4.391

10.  Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarction.

Authors:  David A Bull; Stephen H Bailey; Jeffrey J Rentz; James S Zebrack; Minhyung Lee; Sheldon E Litwin; Sun Wan Kim
Journal:  J Control Release       Date:  2003-12-05       Impact factor: 9.776

View more
  3 in total

1.  Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism.

Authors:  Zhiwen Zhang; Xiaoling Fang; Junguo Hao; Yajuan Li; Xianyi Sha
Journal:  Int J Nanomedicine       Date:  2011-10-07

Review 2.  Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs.

Authors:  Gamaleldin I Harisa; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

3.  Inhibitory effect of a new orally active cedrol-loaded nanostructured lipid carrier on compound 48/80-induced mast cell degranulation and anaphylactic shock in mice.

Authors:  Shreyasi Chakraborty; Nabanita Kar; Leena Kumari; Asit De; Tanmoy Bera
Journal:  Int J Nanomedicine       Date:  2017-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.